C-MER Medical Holdings Limited (stock code: 03309) disclosed a share repurchase and updated issued share information on 04 February 2026. According to the announcement, the opening balance of issued ordinary shares (excluding treasury shares) stood at 1,212,780,870, with an additional 19,562,000 treasury shares. Following a repurchase of 430,000 shares on the market, the total number of treasury shares rose to 19,992,000, while the total number of issued shares remained at 1,232,342,870.

On 04 February 2026, 430,000 shares were repurchased on the Exchange at prices ranging from HKD 1.43 to HKD 1.50, with a total aggregate price of HKD 625,020. The company indicated that no shares were repurchased for cancellation, and all 430,000 repurchased shares were held as treasury shares. The repurchase mandate, granted on 19 May 2025, authorizes up to 125,556,087 shares for possible repurchase. The aggregate repurchases made represented approximately 0.0342% of the issuer’s shares as at the mandate grant date. The announcement recorded a moratorium period until 06 March 2026 for any new share issuance or transfer of treasury shares.